Literature DB >> 6892072

Selective breeding in mice for severity of the ethanol withdrawal syndrome.

G E McClearn, J R Wilson, D R Petersen, D L Allen.   

Abstract

Starting with a foundation population of 200 genetically heterogeneous mice (HS/Ibg), selective breeding has been initiated for a multivariate index of the ethanol withdrawal syndrome. This paper discusses the advantages of using multivariate indices to define pharmacological concepts. The seven variables included in our multivariate index are described. Because five of the seven variables showed a significant sex difference, separate principal component analyses were performed to establish selection indices appropriate for each sex. The study employs within-family mating to minimize inbreeding and includes replicate high, low, and control lines. These selectively bred lines should eventually provide a useful animal model for studying physiological and neurological mechanisms that may be involved in the ethanol withdrawal syndrome.

Entities:  

Mesh:

Year:  1982        PMID: 6892072

Source DB:  PubMed          Journal:  Subst Alcohol Actions Misuse        ISSN: 0191-8877


  4 in total

Review 1.  Selected mouse lines, alcohol and behavior.

Authors:  T J Phillips; D J Feller; J C Crabbe
Journal:  Experientia       Date:  1989-09-15

2.  An alcohol withdrawal test battery measuring multiple behavioral symptoms in mice.

Authors:  Pamela Metten; Jason P Schlumbohm; Lawrence C Huang; Gian D Greenberg; Wyatt R Hack; Stephanie E Spence; John C Crabbe
Journal:  Alcohol       Date:  2017-09-06       Impact factor: 2.405

3.  Ethanol dependence in mice: direct and correlated responses to ten generations of selective breeding.

Authors:  J R Wilson; V G Erwin; J C DeFries; D R Petersen; S Cole-Harding
Journal:  Behav Genet       Date:  1984-05       Impact factor: 2.805

Review 4.  Accelerating discovery for complex neurological and behavioral disorders through systems genetics and integrative genomics in the laboratory mouse.

Authors:  Jason A Bubier; Elissa J Chesler
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.